Fjarde Ap-fonden’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.16M | Buy |
19,000
+3,900
| +26% | +$853K | 0.04% | 362 |
|
|
2025
Q1 | $3.38M | Buy |
15,100
+2,000
| +15% | +$448K | 0.04% | 369 |
|
|
2024
Q4 | $4.29M | Sell |
13,100
-3,300
| -20% | -$1.08M | 0.04% | 367 |
|
|
2024
Q3 | $4.92M | Buy |
+16,400
| New | +$4.92M | 0.05% | 343 |
|
|
2024
Q1 | $5.58M | Buy |
14,100
+1,109
| +9% | +$439K | 0.06% | 318 |
|
|
2023
Q4 | $4.57M | Sell |
12,991
-300
| -2% | -$106K | 0.06% | 349 |
|
|
2023
Q3 | $4.99M | Sell |
13,291
-1,600
| -11% | -$600K | 0.07% | 312 |
|
|
2023
Q2 | $5.7M | Buy |
14,891
+3,500
| +31% | +$1.34M | 0.07% | 288 |
|
|
2023
Q1 | $3.95M | Sell |
11,391
-2,900
| -20% | -$1M | 0.05% | 360 |
|
|
2022
Q4 | $3.36M | Buy |
14,291
+710
| +5% | +$167K | 0.05% | 386 |
|
|
2022
Q3 | $4.11M | Hold |
13,581
| – | – | 0.05% | 383 |
|
|
2022
Q2 | $4.11M | Buy |
13,581
+2,500
| +23% | +$756K | 0.05% | 383 |
|
|
2022
Q1 | $4.55M | Sell |
11,081
-3,900
| -26% | -$1.6M | 0.04% | 408 |
|
|
2021
Q4 | $7.03M | Sell |
14,981
-1,600
| -10% | -$750K | 0.06% | 318 |
|
|
2021
Q3 | $7.04M | Sell |
16,581
-2,473
| -13% | -$1.05M | 0.06% | 309 |
|
|
2021
Q2 | $6.84M | Buy |
19,054
+2,000
| +12% | +$718K | 0.06% | 326 |
|
|
2021
Q1 | $4.81M | Sell |
17,054
-1,300
| -7% | -$366K | 0.04% | 421 |
|
|
2020
Q4 | $5.2M | Buy |
18,354
+4,400
| +32% | +$1.25M | 0.05% | 363 |
|
|
2020
Q3 | $3.84M | Buy |
13,954
+100
| +0.7% | +$27.5K | 0.04% | 415 |
|
|
2020
Q2 | $3.15M | Sell |
13,854
-3,446
| -20% | -$783K | 0.04% | 437 |
|
|
2020
Q1 | $2.63M | Sell |
17,300
-100
| -0.6% | -$15.2K | 0.04% | 419 |
|
|
2019
Q4 | $2.62M | Buy |
+17,400
| New | +$2.62M | 0.03% | 514 |
|